132 related articles for article (PubMed ID: 1808766)
1. A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (Arg to Stop).
Olds RJ; Lane DA; Ireland H; Finazzi G; Barbui T; Abildgaard U; Girolami A; Thein SL
Thromb Res; 1991 Dec; 64(5):621-5. PubMed ID: 1808766
[No Abstract] [Full Text] [Related]
2. Two new nonsense mutations in type Ia antithrombin III deficiency at Leu 140 and Arg 197.
Tomonari A; Iwahana H; Yoshimoto K; Shigekiyo T; Saito S; Itakura M
Thromb Haemost; 1992 Oct; 68(4):455-9. PubMed ID: 1360174
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6.
Emmerich J; Chadeuf G; Alhenc-Gelas M; Gouault-Heilman M; Toulon P; Fiessinger JN; Aiach M
Thromb Haemost; 1994 Oct; 72(4):534-9. PubMed ID: 7878627
[TBL] [Abstract][Full Text] [Related]
4. Ectopic transcript analysis in human antithrombin deficiency.
Perry DJ
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):531-6. PubMed ID: 7578894
[TBL] [Abstract][Full Text] [Related]
5. CpG dinucleotides are "hotspots" for mutation in the antithrombin III gene. Twelve variants identified using the polymerase chain reaction.
Perry DJ; Carrell RW
Mol Biol Med; 1989 Jun; 6(3):239-43. PubMed ID: 2615648
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III: summary of first database update.
Lane DA; Olds RJ; Thein SL
Nucleic Acids Res; 1994 Sep; 22(17):3556-9. PubMed ID: 7937056
[TBL] [Abstract][Full Text] [Related]
7. [Molecular anomalies of coagulation inhibitors].
Aiach M
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):265-6. PubMed ID: 8337141
[No Abstract] [Full Text] [Related]
8. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
Kuhle S; Lane DA; Jochmanns K; Male C; Quehenberger P; Lechner K; Pabinger I
Thromb Haemost; 2001 Oct; 86(4):1007-11. PubMed ID: 11686316
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis in Japanese kindreds of congenital type I antithrombin deficiency causing thrombosis.
Nakahara Y; Tsuji H; Nakagawa K; Masuda H; Kitamura H; Nishimura H; Kasahara T; Sugano T; Sawada S; Nakagawa M
Thromb Haemost; 1997 Apr; 77(4):616-9. PubMed ID: 9134630
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin-III (AT-III) deficiency spanning four generations.
Mazza JJ; Mueller-Rizner NJ; Roberts RC
Thromb Haemost; 1991 Dec; 66(6):737-8. PubMed ID: 1796421
[No Abstract] [Full Text] [Related]
11. Familial antithrombin III deficiency.
O'Donnell J; Day AJ; Snell AP
N Z Med J; 1985 Jun; 98(781):481-3. PubMed ID: 3859772
[No Abstract] [Full Text] [Related]
12. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin cambridge II (Ala384Ser): clinical, functional and haplotype analysis of 18 families.
Perry DJ; Daly ME; Tait RC; Walker ID; Brown K; Beauchamp NJ; Preston FE; Gyde H; Harper PL; Carrell RW
Thromb Haemost; 1998 Feb; 79(2):249-53. PubMed ID: 9493570
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
Molho-Sabatier P; Aiach M; Gaillard I; Fiessinger JN; Fischer AM; Chadeuf G; Clauser E
J Clin Invest; 1989 Oct; 84(4):1236-42. PubMed ID: 2794060
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the molecular biological study of hereditary antithrombin III deficiency].
Chui H; Wang H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):162-4. PubMed ID: 11243148
[No Abstract] [Full Text] [Related]
16. Antithrombin: molecular basis of deficiency.
Bayston TA; Lane DA
Thromb Haemost; 1997 Jul; 78(1):339-43. PubMed ID: 9198176
[TBL] [Abstract][Full Text] [Related]
17. Identification of the antithrombin III Kyoto mutation by restriction fragment length polymorphism analysis.
Masuda H; Tsuji H; Nakagawa K; Nakahara Y; Kitamura H; Ogasahara Y; Nakagawa M
Int J Hematol; 1995 Jun; 61(4):197-204. PubMed ID: 8547608
[TBL] [Abstract][Full Text] [Related]
18. A novel 4 base pair deletion mutation inducing type I antithrombin deficiency.
Ozawa T; Niiya K; Inoue N; Kawahara N; Nakatsuka M; Tada K; Kudo T; Sakuragawa N
Thromb Res; 1997 Mar; 85(6):515-7. PubMed ID: 9101643
[No Abstract] [Full Text] [Related]
19. Screening for mutations in the antithrombin III gene causing recurrent venous thrombosis by single-strand conformation polymorphism analysis.
Millar DS; Lopez A; White D; Abraham G; Laursen B; Holding S; Reverter JC; Reynaud J; Martinowitz U; Hayes JP
Hum Mutat; 1993; 2(4):324-6. PubMed ID: 8401542
[No Abstract] [Full Text] [Related]
20. The confirmation of preclinical familial antithrombin deficiency using polymorphism and specific oligonucleotide probes .
Beresford CH; Hughes PM; Olds R
N Z Med J; 1990 Jun; 103(892):296-8. PubMed ID: 1973278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
